Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Corrigendum to "Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal" [Drug Alcohol Depend. 170 (2017) 43-50].

Auvity S, Goutal S, Thézé B, Chaves C, Hosten B, Kuhnast B, Saba W, Boisgard R, Buvat I, Cisternino S, Tournier N.

Drug Alcohol Depend. 2019 Jun 5. pii: S0376-8716(19)30162-0. doi: 10.1016/j.drugalcdep.2019.05.002. [Epub ahead of print] No abstract available.

PMID:
31176599
2.

Imaging the neuroimmune response to alcohol exposure in adolescent baboons: a TSPO PET study using 18 F-DPA-714.

Saba W, Goutal S, Auvity S, Kuhnast B, Coulon C, Kouyoumdjian V, Buvat I, Leroy C, Tournier N.

Addict Biol. 2018 Sep;23(5):1000-1009. doi: 10.1111/adb.12548. Epub 2017 Sep 25.

PMID:
28944558
3.

Brain Inflammation, Blood Brain Barrier dysfunction and Neuronal Synaptophysin Decrease after Inhalation Exposure to Titanium Dioxide Nano-aerosol in Aging Rats.

Disdier C, Chalansonnet M, Gagnaire F, Gaté L, Cosnier F, Devoy J, Saba W, Lund AK, Brun E, Mabondzo A.

Sci Rep. 2017 Sep 22;7(1):12196. doi: 10.1038/s41598-017-12404-5.

4.

Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal.

Auvity S, Goutal S, Thézé B, Chaves C, Hosten B, Kuhnast B, Saba W, Boisgard R, Buvat I, Cisternino S, Tournier N.

Drug Alcohol Depend. 2017 Jan 1;170:43-50. doi: 10.1016/j.drugalcdep.2016.10.037. Epub 2016 Nov 8. Erratum in: Drug Alcohol Depend. 2019 Jun 5;:.

PMID:
27875800
5.

Biopersistence and translocation to extrapulmonary organs of titanium dioxide nanoparticles after subacute inhalation exposure to aerosol in adult and elderly rats.

Gaté L, Disdier C, Cosnier F, Gagnaire F, Devoy J, Saba W, Brun E, Chalansonnet M, Mabondzo A.

Toxicol Lett. 2017 Jan 4;265:61-69. doi: 10.1016/j.toxlet.2016.11.009. Epub 2016 Nov 16.

PMID:
27865850
6.

Acute Morphine Exposure Increases the Brain Distribution of [18F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates.

Auvity S, Saba W, Goutal S, Leroy C, Buvat I, Cayla J, Caillé F, Bottlaender M, Cisternino S, Tournier N.

Int J Neuropsychopharmacol. 2017 Jan 1;20(1):67-71. doi: 10.1093/ijnp/pyw077.

7.

Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates.

Damont A, Goutal S, Auvity S, Valette H, Kuhnast B, Saba W, Tournier N.

Eur J Pharm Sci. 2016 Aug 25;91:98-104. doi: 10.1016/j.ejps.2016.06.005. Epub 2016 Jun 7.

PMID:
27283486
8.

Validation of a simple HPLC-UV method for rifampicin determination in plasma: Application to the study of rifampicin arteriovenous concentration gradient.

Goutal S, Auvity S, Legrand T, Hauquier F, Cisternino S, Chapy H, Saba W, Tournier N.

J Pharm Biomed Anal. 2016 May 10;123:173-8. doi: 10.1016/j.jpba.2016.02.013. Epub 2016 Feb 15.

PMID:
26907700
9.

Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [(18)F]DPA-714, a positron emission tomography imaging marker of glial activation.

Saba W, Goutal S, Kuhnast B, Dollé F, Auvity S, Fontyn Y, Cayla J, Peyronneau MA, Valette H, Tournier N.

Eur J Neurosci. 2015 Jul;42(1):1738-45. doi: 10.1111/ejn.12946. Epub 2015 Jun 22.

PMID:
25962575
10.

Influence of P-Glycoprotein Inhibition or Deficiency at the Blood-Brain Barrier on (18)F-2-Fluoro-2-Deoxy-D-glucose ( (18)F-FDG) Brain Kinetics.

Tournier N, Saba W, Goutal S, Gervais P, Valette H, Scherrmann JM, Bottlaender M, Cisternino S.

AAPS J. 2015 May;17(3):652-9. doi: 10.1208/s12248-015-9739-3. Epub 2015 Feb 26.

11.

Effects of selected OATP and/or ABC transporter inhibitors on the brain and whole-body distribution of glyburide.

Tournier N, Saba W, Cisternino S, Peyronneau MA, Damont A, Goutal S, Dubois A, Dollé F, Scherrmann JM, Valette H, Kuhnast B, Bottlaender M.

AAPS J. 2013 Oct;15(4):1082-90. doi: 10.1208/s12248-013-9514-2. Epub 2013 Aug 2.

12.

[(18)F]Fallypride: metabolism studies and quantification of the radiotracer and its radiometabolites in plasma using a simple and rapid solid-phase extraction method.

Peyronneau MA, Saba W, Goutal S, Kuhnast B, Dollé F, Bottlaender M, Valette H.

Nucl Med Biol. 2013 Oct;40(7):887-95. doi: 10.1016/j.nucmedbio.2013.06.003. Epub 2013 Jul 25.

PMID:
23891202
13.

Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand.

Peyronneau MA, Saba W, Goutal S, Damont A, Dollé F, Kassiou M, Bottlaender M, Valette H.

Drug Metab Dispos. 2013 Jan;41(1):122-31. doi: 10.1124/dmd.112.046342. Epub 2012 Oct 12.

PMID:
23065531
14.

Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates.

Tournier N, Cisternino S, Peyronneau MA, Goutal S, Dolle F, Scherrmann JM, Bottlaender M, Saba W, Valette H.

Pharm Res. 2012 Sep;29(9):2468-76. doi: 10.1007/s11095-012-0776-7. Epub 2012 May 30.

PMID:
22644589
15.

Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: part II: Metabolism studies.

Peyronneau MA, Saba W, Dollé F, Goutal S, Coulon C, Bottlaender M, Valette H.

Nucl Med Biol. 2012 Apr;39(3):347-59. doi: 10.1016/j.nucmedbio.2011.09.006. Epub 2011 Dec 11.

PMID:
22154687
16.

Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling Part I: PET studies.

Saba W, Peyronneau MA, Dollé F, Goutal S, Bottlaender M, Valette H.

Nucl Med Biol. 2012 Feb;39(2):227-33. doi: 10.1016/j.nucmedbio.2011.08.003. Epub 2011 Oct 26.

PMID:
22033025
17.

Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening.

Tournier N, Valette H, Peyronneau MA, Saba W, Goutal S, Kuhnast B, Dollé F, Scherrmann JM, Cisternino S, Bottlaender M.

J Nucl Med. 2011 Mar;52(3):415-23. doi: 10.2967/jnumed.110.079608. Epub 2011 Feb 14.

18.

[18F]ZW-104, a new radioligand for imaging alpha2-alpha3-alpha4/beta2 central nicotinic acetylcholine receptors: Evaluation in mutant mice.

Saba W, Valette H, Granon S, Xiao Y, Kellar KJ, Dollé F, Bottlaender M.

Synapse. 2010 Jul;64(7):570-2. doi: 10.1002/syn.20776. No abstract available.

PMID:
20222155
19.

In vivo quantification of monoamine oxidase A in baboon brain: a PET study using [(11)C]befloxatone and the multi-injection approach.

Bottlaender M, Valette H, Delforge J, Saba W, Guenther I, Curet O, George P, Dollé F, Grégoire MC.

J Cereb Blood Flow Metab. 2010 Apr;30(4):792-800. doi: 10.1038/jcbfm.2009.242. Epub 2009 Nov 18.

20.

[(11)C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate.

Saba W, Valette H, Peyronneau MA, Bramoullé Y, Coulon C, Curet O, George P, Dollé F, Bottlaender M.

Synapse. 2010 Jan;64(1):61-9. doi: 10.1002/syn.20703.

PMID:
19728365
21.

Evaluation of the impact of the Kuwait Diabetes Care Program on the quality of diabetes care.

Al-Adsani A, Al-Faraj J, Al-Sultan F, El-Feky M, Al-Mezel N, Saba W, Aljassar S.

Med Princ Pract. 2008;17(1):14-9.

22.

[18F]FPhEP and [18F]F2PhEP, two new epibatidine-based radioligands: evaluation for imaging nicotinic acetylcholine receptors in baboon brain.

Valette H, Dollé F, Saba W, Roger G, Hinnen F, Coulon C, Ottaviani M, Syrota A, Bottlaender M.

Synapse. 2007 Sep;61(9):764-70.

PMID:
17568410
23.

Quantification of cerebral nicotinic acetylcholine receptors by PET using 2-[18F]fluoro-A-85380 and the multiinjection approach.

Gallezot JD, Bottlaender MA, Delforge J, Valette H, Saba W, Dollé F, Coulon CM, Ottaviani MP, Hinnen F, Syrota A, Grégoire MC.

J Cereb Blood Flow Metab. 2008 Jan;28(1):172-89. Epub 2007 May 16.

PMID:
17519978
24.

[11C]LBT-999: a suitable radioligand for investigation of extra-striatal dopamine transporter with PET.

Saba W, Valette H, Schöllhorn-Peyronneau MA, Coulon C, Ottaviani M, Chalon S, Dolle F, Emond P, Halldin C, Helfenbein J, Madelmont JC, Deloye JB, Guilloteau D, Bottlaender M.

Synapse. 2007 Jan;61(1):17-23.

PMID:
17068778
25.

Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study.

Picard F, Bruel D, Servent D, Saba W, Fruchart-Gaillard C, Schöllhorn-Peyronneau MA, Roumenov D, Brodtkorb E, Zuberi S, Gambardella A, Steinborn B, Hufnagel A, Valette H, Bottlaender M.

Brain. 2006 Aug;129(Pt 8):2047-60. Epub 2006 Jun 30.

PMID:
16815873
26.

Synthesis and radiosynthesis of [(18)F]FPhEP, a novel alpha(4)beta(2)-selective, epibatidine-based antagonist for PET imaging of nicotinic acetylcholine receptors.

Roger G, Saba W, Valette H, Hinnen F, Coulon C, Ottaviani M, Bottlaender M, Dollé F.

Bioorg Med Chem. 2006 Jun 1;14(11):3848-58. Epub 2006 Feb 7.

PMID:
16455259
27.

Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter.

Chalon S, Hall H, Saba W, Garreau L, Dollé F, Halldin C, Emond P, Bottlaender M, Deloye JB, Helfenbein J, Madelmont JC, Bodard S, Mincheva Z, Besnard JC, Guilloteau D.

J Pharmacol Exp Ther. 2006 Apr;317(1):147-52. Epub 2005 Dec 9.

PMID:
16339913
28.

Synthesis, radiosynthesis and in vivo preliminary evaluation of [11C]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET.

Dollé F, Emond P, Mavel S, Demphel S, Hinnen F, Mincheva Z, Saba W, Valette H, Chalon S, Halldin C, Helfenbein J, Legaillard J, Madelmont JC, Deloye JB, Bottlaender M, Guilloteau D.

Bioorg Med Chem. 2006 Feb 15;14(4):1115-25. Epub 2005 Oct 10.

PMID:
16219467
29.

Multiinjection approach for D2 receptor binding quantification in living rats using [11C]raclopride and the beta-microprobe: crossvalidation with in vitro binding data.

Mauger G, Saba W, Hantraye P, Dolle F, Coulon C, Bramoullé Y, Chalon S, Grégoire MC.

J Cereb Blood Flow Metab. 2005 Nov;25(11):1517-27.

PMID:
15917750
30.

Campaign exposure and interpersonal communication as factors in contraceptive use in Bolivia.

Valente TW, Saba WP.

J Health Commun. 2001 Oct-Dec;6(4):303-22.

PMID:
11783665
31.

Reproductive Health is in Your Hands: the national media campaign in Bolivia.

Valente TW, Saba WP.

SIECUS Rep. 1997 Jan;25(2):10-3.

PMID:
12347727

Supplemental Content

Support Center